Author notes

Joachim Doua

Present address: European and Developing Countries Clinical Trials Partnership (EDCTP), Brussels, Belgium

Authors and Affiliations

Janssen Research and Development, Infectious Diseases and Vaccines, Janssen Pharmaceutica, Beerse, Belgium

Joachim Doua & Bart Spiessens

Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain

Jesús Rodríguez-Baño

Department of Medicine, University of Sevilla and Biomedicine Institute of Sevilla/CSIC, Seville, Spain

Jesús Rodríguez-Baño

CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain

Jesús Rodríguez-Baño

Inserm Clinical Investigation Center 1435, Dupuytren University Hospital, Limoges, France

Rachel Froget

Health Sciences North Research Institute, Sudbury, ON, Canada

Padma Puranam

Janssen Research and Development, Raritan, NJ, USA

Oscar Go

Bacterial Vaccines Discovery and Early Development, Janssen Vaccines & Prevention B.V., Leiden, The Netherlands

Jeroen Geurtsen & Jan Poolman

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands

Sanne van Rooij & Marc Bonten

Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium

Tuba Vilken & Herman Goossens

Department of Respiratory Medicine, Okitama Public General Hospital, 2000, Nishi-Otsuka, Kawanishi, Yamagata, Japan

Inage Minoru

Department of General Internal Medicine, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan

Izumi Yasumori

Division of Infectious Diseases, Department of Diagnostic and Public Health, University of Verona, Verona, Italy

Evelina Tacconelli

Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50924, Cologne, Germany

Lena M. Biehl

German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany

Lena M. Biehl

Department of Medicine, Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA

Joshua T. Thaden

Janssen Vaccines, Branch of Cilag GmbH International, Bern, Switzerland

Michal Sarnecki

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands

Miquel Ekkelenkamp

Consortiaon behalf of the COMBACTE-NET Consortium/EXPECT Study GroupMadison Violette, Sonal Munshi, Moussa Aitabi, Christine Lammens, Sofie Van Mieghem, Sandra Van Puyvelde, Basil Britto Xavier, Anna Maria Azzini, Elda Righi, Nicola Duccio Salerno, Giuliana Lo, Cascio Eleonora Cremonini, Álvaro Pascual, Reinaldo Espíndola, Virginia Palomo, Sarah Walker, Felicia Ruffin, Michael Dagher & Andreja VarjačićContributions

Conceptualization: JD, JR-B, RF, PP, SvR, TV, IM, IY, BS, ET, LMB, JTT, HG, JP, MB, ME. Data Curation: JD, JR-B, RF, PP, OG, JG, SvR, TV, IM, IY, BS, ET, LMB, JTT, MS, HG, JP, MB, ME. Formal Analysis: JD, OG, JG, SvR, TV, BS, MS, JP, ME. Funding Acquisition: JD, JG, SvR, TV, MS, HG, JP, MB. Investigation: JD, JR-B, RF, PP, JG, SvR, TV, IM, IY, BS, ET, LMB, JTT, MS, HG, JP, MB, ME. Methodology: JD, JR-B, RF, PP, OG, JG, SvR, TV, IM, IY, BS, ET, LMB, JTT, MS, HG, JP, MB, ME. Project Administration: JD, OG, JG, SvR, TV, BS, MS, HG, JP, MB, ME. Resources: JD, JR-B, RF, PP, OG, JG, SvR, TV, IM, IY, BS, ET, LMB, JTT, MS, HG, JP, MB, ME. Software: JD, OG, JG, SvR, TV, BS, MS, HG, JP, MB, ME. Supervision: JD, JG, SvR, TV, BS, MS, HG, JP, MB, ME. Validation: JD, JR-B, RF, PP, JG, SvR, TV, IM, IY, BS, ET, LMB, JTT, MS, HG, JP, MB, ME. Visualization: JD, JR-B, RF, PP, OG, JG, SvR, TV, IM, IY, BS, ET, LMB, JTT, MS, HG, JP, MB, ME. Writing – Original Draft Preparation: JD, OG, JG, TV, BS, MS, HG, JP, MB, ME Writing – Review & Editing: JD, JR-B, RF, PP, OG, JG, SvR, TV, IM, IY, BS, ET, LMB, JTT, MS, HG, JP, MB, ME.

Corresponding author

Correspondence to Michal Sarnecki.